Who invested in Somaxon Pharmaceuticals?
Somaxon Pharmaceuticals's investors include Domain Associates, Montreux Growth Partners, BA Venture Partners, CDIB BioScience Ventures and Fog City Capital, and 1 more on record.

United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$94Mraised across 3 rounds since 2004, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $6.0M sold, first sale Jul 2009
No investor was named in the report.
From a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Somaxon Pharmaceuticals's investors include Domain Associates, Montreux Growth Partners, BA Venture Partners, CDIB BioScience Ventures and Fog City Capital, and 1 more on record.
Somaxon Pharmaceuticals has raised $94M across 3 rounds since 2004.
Somaxon Pharmaceuticals's most recent round was a Venture of $6.0M in Jul 2009.
Somaxon Pharmaceuticals's largest round on record is $65M (Series C), in Jun 2005.
Somaxon Pharmaceuticals's first round on record, in Jun 2004, was backed by Domain Associates, Montreux Growth Partners and BA Venture Partners and 3 others.
Somaxon Pharmaceuticals's latest named round is a Venture, in Jul 2009.
Somaxon Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.